Raloxifene for prevention of glucocorticoid-induced bone loss: a 12-month randomised double-blinded placebo-controlled trial.

Mok, Chi Chiu; Ying, King Yee; To, Chi Hung; Ho, Ling Yin; Yu, Ka Lung; Lee, Hon Kit; Ma, Kwok Man

Mok, Chi Chiu; Ying, King Yee; To, Chi Hung; Ho, Ling Yin; Yu, Ka Lung; Lee, Hon Kit; Ma, Kwok Man.

Affiliation

Mok CC; Department of Medicine, Tuen Mun Hospital, Tsing Chung Koon Road, New Territories, Hong Kong, SAR China. ccmok2005@yahoo.com

Ann Rheum Dis ; 70(5): 778-84, 2011 May.

Article in En | MEDLINE | ID: mdl-21187295

Subject(s)

Bone Density Conservation Agents/therapeutic use; Glucocorticoids/adverse effects; Osteoporosis, Postmenopausal/prevention & control; Raloxifene Hydrochloride/therapeutic use; Biomarkers/metabolism; Bone Density/drug effects; Bone Density Conservation Agents/adverse effects; Double-Blind Method; Drug Administration Schedule; Female; Glucocorticoids/administration & dosage; Glucocorticoids/therapeutic use; Hip Joint/physiopathology; Humans; Lipids/blood; Lumbar Vertebrae/physiopathology; Middle Aged; Osteoporosis, Postmenopausal/chemically induced; Osteoporosis, Postmenopausal/physiopathology; Prednisone/administration & dosage; Prednisone/adverse effects; Prednisone/therapeutic use; Raloxifene Hydrochloride/adverse effects; Rheumatic Diseases/drug therapy

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Osteoporosis, Postmenopausal / Raloxifene Hydrochloride / Bone Density Conservation Agents / Glucocorticoids Type of study: Clinical_trials / Risk_factors_studies Limits: Female / Humans / Middle aged Language: En Journal: Ann Rheum Dis Year: 2011 Document type: Article Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google